Suppr超能文献

支气管扩张剂吸入气雾剂推进剂对呼吸气体监测仪的影响。

The effects of bronchodilator-inhaler aerosol propellants on respiratory gas monitors.

作者信息

Elliot W R, Raemer D B, Goldman D B, Philip J H

机构信息

Department of Anesthesia, Brigham and Women's Hospital, Boston, MA 02115.

出版信息

J Clin Monit. 1991 Apr;7(2):175-80. doi: 10.1007/BF01618119.

Abstract

Spurious readings from a mass spectrometer have been reported following the administration of aerosol bronchodilators. We quantified the response of various respiratory gas analyzers to the aerosol propellant of albuterol inhalant (Proventil). The mass spectrometer systems tested, two Advantage systems, a SARA system, and a Model 6000 Ohmeda system, all displayed artifactual readings in response to the albuterol propellant. Each metered dose of the Proventil brand of albuterol contains 4 ml of Freon 11 (trichloromonofluoromethane) and 11 ml of Freon 12 (dichlorodifluoromethane). The concentration of propellant was expressed in doses/L, where each liter of gas contains 0.4 vol % of Freon 11 and 1.1 vol % of Freon 12 per dose. In proportion to the concentration of albuterol propellant, the two Advantage systems showed substantial readings of isoflurane (%) when no isoflurane was present (13% and 16% per dose/L) and reduced readings of enflurane (-8% and -10% per dose/L) and carbon dioxide (CO2) (-3 and +5 mm Hg per dose/L). The SARA system showed substantial CO2 readings when no CO2 was present (5 mm Hg per dose/L) and displayed small enflurane readings (0.1% per dose/L) when no enflurane was present. The Model 6000 unit showed CO2 readings when no CO2 was present (5 mm Hg per dose/L). Neither the Raman spectrometer, the infrared spectrometers, nor the piezoadsorptive analyzer we tested showed an artifactual effect of albuterol propellant on any of its readings. Simulation and clinical tests demonstrated that a single dose of albuterol propellant into a breathing circuit at the onset of inspiration resulted in concentrations of 0.8 and 0.3 dose/L, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

据报道,在使用气溶胶支气管扩张剂后,质谱仪会出现假性读数。我们对各种呼吸气体分析仪对沙丁胺醇吸入剂(喘乐宁)的气溶胶推进剂的反应进行了量化。所测试的质谱仪系统,两台Advantage系统、一台SARA系统和一台6000型欧美达系统,对沙丁胺醇推进剂均显示出伪读数。喘乐宁品牌的沙丁胺醇每计量剂量含有4毫升氟利昂11(三氯一氟甲烷)和11毫升氟利昂12(二氯二氟甲烷)。推进剂浓度以剂量/升表示,每升气体每剂量含有0.4体积%的氟利昂11和1.1体积%的氟利昂12。与沙丁胺醇推进剂浓度成比例,两台Advantage系统在无异氟烷时显示出大量的异氟烷(%)读数(每剂量/升为13%和16%),而恩氟烷(每剂量/升为-8%和-10%)和二氧化碳(CO2)(每剂量/升为-3和+5毫米汞柱)的读数降低。SARA系统在无CO2时显示出大量的CO2读数(每剂量/升为5毫米汞柱),在无恩氟烷时显示出少量的恩氟烷读数(每剂量/升为0.1%)。6000型仪器在无CO2时显示出CO2读数(每剂量/升为5毫米汞柱)。我们测试的拉曼光谱仪、红外光谱仪和压阻吸附分析仪均未显示沙丁胺醇推进剂对其任何读数有伪效应。模拟和临床试验表明,在吸气开始时将单剂量的沙丁胺醇推进剂注入呼吸回路,浓度分别为0.8和0.3剂量/升。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验